chartexchange

SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

GlobeNewswire Inc. | Oct 19, 2026 8:00 AM EDT

Groundbreaking 4-year safety and efficacy results:

Read original article